• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骶神经调节术中骨标志的变异及成功的预测因素

Variation in bony landmarks and predictors of success with sacral neuromodulation.

作者信息

Husk Katherine E, Norris Lauren D, Willis-Gray Marcella G, Borawski Kristy M, Geller Elizabeth J

机构信息

Division of Female Pelvic Medicine and Reconstructive Surgery, University of North Carolina Chapel Hill, Chapel Hill, NC, 27599-7570, USA.

Department of Urology, University of North Carolina Chapel Hill, Chapel Hill, NC, USA.

出版信息

Int Urogynecol J. 2019 Nov;30(11):1973-1979. doi: 10.1007/s00192-019-03883-3. Epub 2019 Feb 7.

DOI:10.1007/s00192-019-03883-3
PMID:30729252
Abstract

INTRODUCTION AND HYPOTHESIS

We assessed variations in sacral anatomy and lead placement as predictors of sacral neuromodulation (SNM) success. Based solely on bony landmarks, we also assessed the accuracy of the 9 and 2 protocol for locating S3.

METHODS

This is a retrospective cohort study performed from October 2008 to December 2016 at the University of North Carolina at Chapel Hill. Fluoroscopic images were used to assess sacral anatomy and lead location. Success was defined as >50% symptom improvement after stage I and clinical response at most recent follow-up.

RESULTS

Of 249 procedures, 209 were primary implants and 40 were revisions among 187 (89.5%) women and 22 (10.5%) men. Success rate was 83.3% for primary implants and 89.4% for revisions. Success was associated with shorter implant duration (21.3 ± 22.2 vs 33.6 ± 25.8 months), higher body mass index (30.3 ± 7.8 vs 27.6 ± 6.1 kg/m), and straight vs curved lead (90.5% vs 80.5%) (all p = .05), but not with sacral anatomy or lead placement. In assessing the 9 and 2 protocol, mean distance from coccyx to S3 did not equal 9 cm: 7.4 ± 1.0 vs 7.2 ± 0.8 cm (p = .26), while mean distance from midline to S3 did equal 2 cm: 1.9 ± 0.4 vs 2.0 ± 0.7 cm (p = .37).

CONCLUSIONS

Variations in sacral anatomy and lead placement did not predict SNM success. The 2-cm protocol was verified while the 9-cm protocol was not, although neither was predictive of success, which may obviate the need to mark bony landmarks prior to fluoroscopy.

摘要

引言与假设

我们评估了骶骨解剖结构和电极放置的差异,以此作为骶神经调节(SNM)成功的预测指标。仅基于骨性标志,我们还评估了9和2方案定位S3的准确性。

方法

这是一项回顾性队列研究,于2008年10月至2016年12月在北卡罗来纳大学教堂山分校进行。利用荧光镜图像评估骶骨解剖结构和电极位置。成功定义为I期后症状改善>50%且在最近一次随访时有临床反应。

结果

在249例手术中,187例(89.5%)女性和22例(10.5%)男性中有209例为初次植入,40例为翻修。初次植入的成功率为83.3%,翻修的成功率为89.4%。成功与植入时间较短(21.3±22.2 vs 33.6±25.8个月)、体重指数较高(30.3±7.8 vs 27.6±6.1kg/m)以及直线型与曲线型电极(90.5% vs 80.5%)相关(所有p=0.05),但与骶骨解剖结构或电极放置无关。在评估9和2方案时,从尾骨到S3的平均距离并不等于9cm:7.4±1.0 vs 7.2±0.8cm(p=0.26),而从中线到S3的平均距离确实等于2cm:1.9±0.4 vs 2.0±0.7cm(p=0.37)。

结论

骶骨解剖结构和电极放置的差异并不能预测SNM的成功。2cm方案得到了验证,而9cm方案未得到验证,尽管两者都不能预测成功,这可能使得在荧光镜检查前无需标记骨性标志。

相似文献

1
Variation in bony landmarks and predictors of success with sacral neuromodulation.骶神经调节术中骨标志的变异及成功的预测因素
Int Urogynecol J. 2019 Nov;30(11):1973-1979. doi: 10.1007/s00192-019-03883-3. Epub 2019 Feb 7.
2
Sacral neuromodulation: sacral anatomy and optimal lead placement.骶神经调节:骶骨解剖与最佳电极放置。
Int Urogynecol J. 2021 Sep;32(9):2545-2547. doi: 10.1007/s00192-020-04615-8. Epub 2020 Nov 25.
3
Surface and boney landmarks for sacral neuromodulation: a cadaveric study.骶神经调节的表面和骨性标志:一项尸体研究。
Int Urogynecol J. 2015 Feb;26(2):263-8. doi: 10.1007/s00192-014-2504-9. Epub 2014 Sep 26.
4
Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique.采用优化的导丝放置技术的当代队列中骶神经调节的结果。
Neurourol Urodyn. 2019 Aug;38(6):1595-1601. doi: 10.1002/nau.24018. Epub 2019 May 1.
5
Sacral neuromodulation: troubleshooting needle placement.骶神经调节:故障排除针的放置。
Int Urogynecol J. 2021 Sep;32(9):2549-2551. doi: 10.1007/s00192-020-04614-9. Epub 2021 Jan 8.
6
Third sacral foramina morphometry for sacral neuromodulation.用于骶神经调节的第三骶孔形态测量学
Female Pelvic Med Reconstr Surg. 2013 Jan-Feb;19(1):23-30. doi: 10.1097/SPV.0b013e31827bfdb1.
7
First-in-human implantation of a mid-field powered neurostimulator at the sacral nerve: Results from an acute study.首次在人体骶神经植入中场功率神经刺激器:一项急性研究结果。
Neurourol Urodyn. 2019 Aug;38(6):1669-1675. doi: 10.1002/nau.24035. Epub 2019 May 20.
8
Strategies for Difficult Fluoroscopic Landmarking During Sacral Neuromodulation Lead Placement.骶神经调节电极置入过程中困难荧光透视定位的策略
Urology. 2023 Apr;174:218-220. doi: 10.1016/j.urology.2022.12.029. Epub 2023 Jan 11.
9
Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device.远程程控骶神经调节治疗难治性膀胱过度活动症患者:一种新型骶神经调节装置评估安全性和有效性的前瞻性随机对照试验。
World J Urol. 2019 Nov;37(11):2481-2492. doi: 10.1007/s00345-019-02698-7. Epub 2019 Feb 26.
10
Is sensory testing during lead placement crucial for achieving positive outcomes after sacral neuromodulation?在骶神经调节后,进行电极放置时的感觉测试对于获得积极的结果是否至关重要?
Neurourol Urodyn. 2011 Nov;30(8):1489-92. doi: 10.1002/nau.21122. Epub 2011 Jun 14.

本文引用的文献

1
Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized Trial.骶神经调节与肉毒毒素 A 治疗难治性急迫性尿失禁的两年结局:一项随机试验。
Eur Urol. 2018 Jul;74(1):66-73. doi: 10.1016/j.eururo.2018.02.011. Epub 2018 Feb 24.
2
Refractory urgency urinary incontinence treatment in women: impact of age on outcomes and complications.女性难治性急迫性尿失禁的治疗:年龄对结局和并发症的影响
Am J Obstet Gynecol. 2018 Jan;218(1):111.e1-111.e9. doi: 10.1016/j.ajog.2017.10.006. Epub 2017 Oct 12.
3
Sacral Neuromodulation: Standardized Electrode Placement Technique.
骶神经调节:标准化电极放置技术。
Neuromodulation. 2017 Dec;20(8):816-824. doi: 10.1111/ner.12695. Epub 2017 Oct 4.
4
Optimal Lead Positioning in Sacral Neuromodulation: Which Factors Are Related to Treatment Outcome?骶神经调节中电极的最佳定位:哪些因素与治疗结果相关?
Neuromodulation. 2017 Dec;20(8):830-835. doi: 10.1111/ner.12649. Epub 2017 Sep 6.
5
Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence.与接受肉毒杆菌毒素 A 和骶神经调节治疗难治性急迫性尿失禁的女性治疗反应和满意度相关的特征。
J Urol. 2017 Oct;198(4):890-896. doi: 10.1016/j.juro.2017.04.103. Epub 2017 May 10.
6
Impact of Age and Comorbidities on Use of Sacral Neuromodulation.年龄和合并症对骶神经调节应用的影响。
J Urol. 2017 Jul;198(1):161-166. doi: 10.1016/j.juro.2017.02.020. Epub 2017 Feb 10.
7
Surface anatomical landmarks for the location of posterior sacral foramina in sacral nerve stimulation.骶神经刺激中后骶孔位置的表面解剖标志。
Tech Coloproctol. 2016 Dec;20(12):859-864. doi: 10.1007/s10151-016-1543-2. Epub 2016 Nov 14.
8
Outcomes of Sacral Neuromodulation in a Privately Insured Population.私人保险人群中骶神经调节的治疗效果
Neuromodulation. 2016 Oct;19(7):780-784. doi: 10.1111/ner.12472. Epub 2016 Aug 5.
9
Long-term outcomes of sacral nerve stimulation for faecal incontinence.经直肠刺激治疗大便失禁的长期疗效。
Br J Surg. 2015 Mar;102(4):407-15. doi: 10.1002/bjs.9740. Epub 2015 Feb 2.
10
Surface and boney landmarks for sacral neuromodulation: a cadaveric study.骶神经调节的表面和骨性标志:一项尸体研究。
Int Urogynecol J. 2015 Feb;26(2):263-8. doi: 10.1007/s00192-014-2504-9. Epub 2014 Sep 26.